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Personality and cannabis use 
Abstract 
Cannabis is one of the most widely used illegal substances in the world. Its use has been reported to be 
over-represented in many psychiatric conditions and has frequently been found to predate the onset of 
psychiatric symptoms. However, cannabis may also have detrimental effects on the general population. 
Factors that predict the onset of use are receiving increased attention to aid in identifying groups of 
young people who may be more prone to consume cannabis. Personality traits may be one such factor as 
they are readily identifiable and offer information that can be used for improved targeting of educational 
material about the effects of cannabis use. This review summarizes the role that personality traits may 
play in cannabis use, with a focus on impulsivity and schizotypy, both of which have been extensively 
studied for their contribution in this setting. Additionally, other traits and the potential overlap between 
personality traits are highlighted. The wider implications of a better understanding of personality traits 
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Cannabis is one of the most commonly used illegal
substances worldwide [1]. Use in the UK appears to be
increasing at an even higher rate than in other countries
perceived to have a more pernicious drug problem, such as
the US. Cannabis use is associated with both acute and
chronic health risks to the individual, resulting in increasing
costs to society, and therefore presents a problem that needs
urgent attention. 
First use of cannabis usually occurs in adolescence and
the negative impact that the drug can have on academic and
social functioning, as well as mental health, has been widely
documented [2–4]. Predictors of continued cannabis use into
adulthood include many factors that are not amenable to
intervention, such as gender [e.g. 5]. Since even short-term
heavy cannabis use can have a detrimental effect in the long
term, such as a negative impact upon educational
achievement due to impaired working memory and learning
capabilities [6], interventions and educational programs need
to be targeted at prevention, reduction, and cessation of use
in young people. In order for a greater awareness of the
attraction that cannabis holds, the role of constant and life-
long factors in predicting use need to be better understood.
One of the most stable factors across the life span is
personality. Personality may be of particular importance in
determining what predicts the onset of cannabis use in
young adults as it is during adolescence that the
development and establishment of adult personality occurs. 
There is some controversy surrounding the reasons for
cannabis use in the general population, with some
investigators suggesting that people are self-medicating
unwanted aspects of their personality or the effects of other
drugs. It is hypothesized that individuals are drawn to using
the drug to moderate underlying biological imbalances and
the expression of particular behaviors or emotional
responses. Although there is no consistent evidence for self-
medication of extreme expression of personality traits [7],
the reasons for cannabis use in both clinical subgroups and
the general population have not been fully explored;
therefore, it would seem premature to rule this out as an
explanation, at least in part. 
This review aims to summarize the current literature on
personality and cannabis use, with particular emphasis on
impulsivity and schizotypy and how these traits may mediate
a susceptibility towards drug use initiation.
In collating data for this review, literature searches were
performed using key words such as “personality”,
“impulsivity”, “novelty seeking”, “schizotypy”, “psychosis
proneness”, and “cannabis”. The reference sections of
relevant articles were then searched for reports that would
contribute to the subject. The current review is by no means
exhaustive, as both impulsivity and schizotypy could,
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of data available on these traits and cannabis use. The
articles examined take a continuous-trait approach to
personality and do not use cut-offs to indicate clinical or
non-clinical status. The current review aims to summarize
key arguments within the literature published to date on the
role of personality and its associations with cannabis use.
There are only a small number of longitudinal studies that
have considered the role of personality in patterns of
cannabis use; hence, unless otherwise stated, the
investigations described are cross-sectional. 
Impulsivity 
Impulsivity is believed to play a role in many risk-taking
behaviors, including illicit drug use. In particular, its role in the
use of methylenedioxymethamphetamine, or “ecstasy”, and
the impact that this drug has on impulsivity, has been widely
explored because of their shared underlying neurobiology of
the serotonin system [8,9]. To date, no longitudinal studies
have been performed to determine whether impulsivity leads
to drug use or whether drug use leads to elevated impulsivity
[e.g. 10]. However, an indication of the stability of the
relationship between impulsivity and cannabis use can be
sought by considering whether it is associated with use per
se, current use, and the degree of use.
Impulsivity is a trait characterized by motor, attentional,
and non-planning components [11]. The motor component
is demonstrated in behaviors such as acting on the spur of
the moment, an inability to sit still, and general levels of
agitation. The attentional component is indicated by a lack
of focus and sustained effort in cognitive tasks. The non-
planning component contains both cognitive factors, such as
planning and thinking ahead, and more general indicators of
self-control relating to the ability to finish a task and the
degree of caution applied to daily life. Novelty or sensation
seeking and risk taking are behavioral evidence of these
components and may be the most important aspects of
impulsivity in predicting drug use. Novelty seeking is the
trait that has been most frequently studied when
considering the role of impulsivity in cannabis use. 
For individuals who express impulsive tendencies,
cannabis may have a relaxing and calming influence [12].
Anecdotal evidence for this comes from reports that
cannabis is often used to alleviate the unpleasant effects
following ecstasy use (“coming down”) [e.g. 13]. This has
been proposed as evidence that cannabis is used to self-
medicate for unwanted reactions to ecstasy. Previous studies
have shown that those who have high scores when tested
for impulsivity are more likely to use cannabis [7,14–16] and
to use the drug more heavily [e.g. 17]. Furthermore,
impulsivity is associated with current use of cannabis
[e.g. 7,15,16]. 
Hypomania is thought to be normally distributed in the
general population, with impulsivity comprising a large
proportion of the many aspects of this trait [18]. In an
epidemiological study, Henquet and colleagues reported an
association between cannabis use and hypomanic symptoms
in the general population. This association remained after
controlling for baseline mania, psychosis, and other
psychiatric symptoms, as well as demographic variables and
use of other drugs [19]. 
However, associations between cannabis and impulsivity
have not been consistently reported. For example, Adams
and colleagues found that low novelty seeking scores were
associated with tobacco and cannabis use, while high scores
were associated with polysubstance use [20]. Chakroun et
al. reported that cannabis users had high novelty seeking
scores compared with individuals who had not used any
substances, and that polysubstance users had the highest
novelty seeking scores of all the groups studied [15]. It may
be that cannabis use has become perceived as too
conservative for highly impulsive individuals and that they
favor more “adventurous” drug taking, resulting in a – in
relative terms – “mild” form of impulsivity being expressed
among those who still prefer smoking cannabis. 
Sensation seeking has also been shown to be associated
with current cannabis use and prediction of future use in
adolescents [21]. However, Donohew and colleagues
suggest that the relationship between sensation seeking and
drug use in adolescents may not be a simple one [22]. They
report that the sensation-seeking levels of adolescents’ peers
predicted drug use 2 years later more directly than the
adolescent’s own sensation-seeking scores. This has been
replicated more recently in a study specifically examining
cannabis use [23]. Romer and Hennessy described a
biosocial-affect model, in which the likelihood of cannabis
use was mediated by affective evaluation of cannabis
effects, peer attraction to risky behavior, and individual
differences in sensation-seeking, with no direct relationship
between sensation seeking behavior and cannabis use.
These studies highlight that personality needs to be
considered in a wider social and interpersonal context,
where some traits may be protective against cannabis use
whereas others could leave individuals more open to being
influenced by others, thereby mediating a susceptibility to
drug use initiation.
The literature includes some limited evidence for a
relationship between biological vulnerability, personality, and
a negative outcome from cannabis use. Reports of cannabis
consumption leading to violence in a small number of
individuals have been published and it is possible that
impulsivity is mediating this relationship [e.g. 24–26], in that
persons who are impulsive may be more likely to become
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violent after using cannabis. Neurobiological differences in
people who use cannabis may explain this association. In an
assessment of brain activation during a “go–no go” task,
Tapert and colleagues demonstrated that individuals with a
history of cannabis use had an elevated blood oxygen level-
dependent signal compared with non-users, indicating
increased brain activity [27]. The go–no go task is a measure
of response inhibition; those who score highly on impulsivity
have to complete the task with greater care in order to
inhibit their response. These results suggest that greater
cognitive effort is required to complete this task successfully
following cannabis use. Therefore, those who are impulsive
will have to work harder to inhibit their behavior following
cannabis use given that they are already less inhibited
compared with their less impulsive counterparts. 
In summary, there appears to be a close relationship
between impulsivity and cannabis use. However, individuals
who express particularly high levels of impulsivity may prefer
the excitement of polysubstance drug use to the more readily
available and seemingly commonplace cannabis. Impulsivity
may not be elevated by cannabis use but there is some
evidence suggesting that expression of impulsivity influences
the experiences that individuals have when using cannabis. 
Schizotypy 
Due to their proximity to psychosis, the relationship between
schizotypal traits, or schizotypy, and cannabis has been
investigated extensively. Schizotypy is a normally distributed
trait in the general population of hypothetical proneness to
psychosis [e.g. 28]. It is characterized by attenuated
psychotic symptoms, unusual belief systems, social
withdrawal, and some negative symptoms in the form of
anxiety and depression [e.g. 29]. In a 20-year prospective
community study of psychotic experiences in the general
population, schizotypal traits were associated with adverse
psychiatric and social outcomes [30]. Psychotic symptoms in
individuals with schizotypal traits have been shown to be
mediated by the same factors reported in patients with
schizophrenia, including urbanicity [31], stress [e.g. 32], and
cannabis use [33,34]. 
Schizotypal traits have been associated with cannabis use
in some studies [35–42], but not in others [e.g. 33, see 43
for a cautionary note]. Schizotypal traits are also associated
with more frequent or persistent cannabis use [37,44].
It is difficult to determine whether schizotypal traits predate
cannabis use; however, a number of longitudinal studies have
tried to address this question. van Os and colleagues
conducted a 3-year investigation and reported that cannabis
use increased the likelihood of psychotic symptoms, but that
the effect was more pronounced in those who had a
proneness to psychosis at baseline [45]. Schiffman et al. took a
novel approach to determining whether schizotypal traits
predated the onset of cannabis use: they asked participants to
rate when they first started to notice the traits and determined
whether they predated the average age of first cannabis use
[46]. They found that most schizotypal traits predated the
onset of cannabis use.
Given that some features of schizotypy may precede the
onset of cannabis use, it is possible that high schizotypal
individuals may be self-medicating. There is some evidence
that individuals with schizotypal traits are more sensitive to
the effects of cannabis [33,34,47]; this would mean that
they may be more likely to experience the pleasurable and
relaxing effects, as well as the psychosis-like effects.
However, Pedersen reported that cannabis use initiation was
not predicted by mental health problems in 16–19-year-old
adolescents [48]. Additionally, Stefanis and colleagues found
that cannabis use in persons with high schizotype
personalities was not associated with the distress they
experienced as a result of their unusual experiences [37]. 
It seems that schizotypal traits may be associated with
cannabis use and there is some suggestion that the
schizotypal traits predate the onset of cannabis use.
However, the data from van Os et al. suggest that cannabis
can induce psychotic symptoms even in those who do not
have any proneness to psychosis [45]. Additionally, Solowij
and Michie have gone as far as proposing that long-term
cannabis users are an endophenotypic model for the
cognitive symptoms of schizophrenia [49]. It is possible that
heavy or long-term cannabis use may produce neuro-
biological changes that could lead to the development of
schizotypal traits. Cannabis use does result in functional
changes in some brain areas that are also affected in
schizophrenia, such as the frontal lobes and hippocampus, as
well as alterations in global cortical blood flow [e.g. 50,51]. 
The relationship between cannabis, schizotypy, and
psychotic symptoms is controversial. There is emerging
evidence that schizotypal traits predate the onset of
cannabis use and perhaps cannabis use exacerbates the
expression of schizotypy. In order to determine whether
cannabis use causes the expression of high schizotypal traits,
examination of a longitudinal database is required to
determine whether there is an association between
increasing rates of cannabis use and population levels of
schizotypal traits. Long-term cannabis users do exhibit many
of the cognitive deficits seen in patients with schizophrenia,
some or all of which may be underpinned by neuro-
biological changes.
Other personality traits
Impulsivity and schizotypy are the most widely studied traits
in relation to use of cannabis, both as a cause and as an
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effect. One study reported that cannabis use was associated
with low scores for conscientiousness in a group of young
adolescent social drinkers [51]. Other investigators have
adopted a somewhat different approach. A number of large
studies have examined the expression of psychiatric
symptoms in the general population and their association
with cannabis use [53,54]. The research on subclinical
psychiatric symptoms mirrors the interest in schizotypy;
perhaps they reflect an extreme of personality that, under
particular circumstances, leaves an individual prone to the
expression of a full psychiatric disorder. 
In a general population study, cannabis use before the
age of 15 years correlated with a greater incidence of
depression and anxiety in early adulthood; this result
remained significant after correction for confounds such as
use of other drugs [53]. In another investigation, weekly or
frequent smoking of cannabis was associated with clinically
defined (at interview) depression and anxiety; the reverse
causation did not exist in this study, i.e. adolescents with
depression or anxiety were not more likely to smoke
cannabis than those without depression or anxiety [54].
Additionally, anxiety has been identified as one of 
the personality factors that predicts severity of cannabis 
use [55,56]. 
Social anxiety has been specifically investigated since
reduction of anxiety in social situations may be evidence of
the self-medication hypothesis for cannabis use. In a non-
clinical sample, an association was reported between
symptoms of social anxiety and symptoms of cannabis
dependence [57]. In a clinically recruited cohort of
adolescents, a baseline diagnosis of social anxiety correlated
with increased risk of cannabis dependence at follow-up
[58]. This association did not extend to other anxiety
disorders. These two studies suggest that individuals who
are prone to social anxiety may be more likely to use
cannabis. This situation may not be as clear cut for all
anxiety disorders. A recent systematic review demonstrated
a significant association between cannabis use and first
major depressive episode, but the association with anxiety
disorders disappeared after correcting for confounding
factors [59]. 
Anxiety and depression have been treated as continuous
traits rather than discrete categories in most studies
investigating associations with cannabis use. There is a
limitation to these investigations in that they are concerned
with the frequency of psychiatric symptoms in the general
population rather than using measures that allow a
proneness to these disorders to be determined. However, it
appears that anxious and depressive symptoms do present
after cannabis use, but whether this only occurs in those
prone to these symptoms is yet to be determined.
Possible overlap between traits 
Two models explaining the emergence of drug use in
adolescence and its persistence into problem drug use were
developed during the 1970s and 1980s: the socialization
theory [60] and the theory of problem behavior proneness
[63]. At the centre of both is an interaction between a
number of personality traits, along with environmental
stressors such as parental divorce and instability, and the
degree of engagement the young person has with societal
norms. Both impulsivity and schizotypy, and specifically
delusional proneness, may predispose individuals to
developing beliefs that are not congruent with societal
norms. Pedersen reported that subcultural belief systems
along with poor mental health and parental divorce
predicted heavy cannabis use in 17–20-year-olds, whereas
just experimenting with the drug was predicted by
subcultural beliefs alone [48]. These results suggest that
individuals with unusual beliefs who do not conform to
societal norms may experiment with cannabis, but that
additional destabilizing factors are required for an individual
to be prone to heavier use of cannabis. 
Perhaps the role of personality in predicting cannabis use
should be considered in an additive fashion, with increasing
extreme high scoring on particular traits that are more likely
to lead to problem cannabis use. Furthermore, the greater
the number of personality traits that an individual possesses
in their extreme form, the less likely the person is to be
influenced by societal norms. 
Personality traits may confer a risk for cannabis use
through two different mechanisms: the social deviance
model and the self-medication model [7]. In the social
deviance model, those who score highly on certain
personality traits are less likely to be influenced by societal
norms and, therefore, more likely to engage in deviant
behaviour. An alternative to this theory may be that
cannabis use and extreme personality are both an expression
of dysfunction but may co-exist with a third variable that
increases the likelihood of cannabis use. For example, both
the socialization theory [60] and the theory of problem
behavior proneness [63] highlight the role for peer groups in
mediating risk-taking in adolescents. Those with extremes of
personality may be more drawn to one another and exert
social pressure upon other group members to engage in
further risk-taking behaviors, which they may have inhibited
in other social circles. 
An alternative biological example may be that the
expression of extreme scores on some personality measures
is indicative of an underlying biological proneness to
psychopathology. Individuals will be drawn to using
particular substances due to their pharmacological
properties, in order to counter some internal abnormality in
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a particular neurotransmitter system – the self-medication
hypothesis. However, cannabis has a non-specific
pharmacological effect, targeting γ-aminobutyric acid
(GABA) directly and dopamine and serotonin indirectly
[63–66]. Therefore, it is difficult to conclude which trait
would draw individuals to self-medicate using cannabis. 
General conclusions and future research 
Given that personality traits are readily recognizable and
could be used to identify those individuals who are most
likely to initiate cannabis use during adolescence, there have
been relatively few studies examining their role in this
context. Additionally, the mechanisms through which
personality traits may increase the likelihood of cannabis use
have not been tested or fully explored, nor whether certain
combinations of traits increase the risk for cannabis use.
Personality may also be a confounding factor in many
longitudinal studies examining patterns of cannabis use in
different populations. Gender is a potential confound to
both studies of personality and cannabis use. For example,
males are more likely to smoke cannabis and also score
significantly higher on impulsivity and the negative aspects
of schizotypy [e.g. 61]. Martin and colleagues reported that
sensation-seeking scores among cannabis users in their
sample were higher for males than for females [62]. 
Individual differences in response to cannabis use are
now becoming well documented [e.g. 33,47]. The
persistence in the reporting of inter-individual variation
suggests that there may be an intermediary variable
accounting for differing sensitivities to cannabis. Personality
may be such an intermediate variable. Expression of
particular personality traits may be biologically determined
[e.g. 67], and the same biological mechanisms may underpin
individual differences in experiences with cannabis. If
psychiatric diseases can be considered at the extreme end of
personality traits such as schizotypy, the experiences that
people report after cannabis use could reveal the underlying
tendency a person may have towards a particular psychiatric
condition. From a biological perspective, the non-specific
mode of action of cannabis may highlight whether an
individual is sensitive to fluctuations in levels of dopamine,
serotonin, or GABA, which could be exacerbated by
cannabis use and expressed behaviorally in the experiences
the person reports after use. 
There is a need for further systematic research to be
conducted to clarify the relationship between personality
and cannabis use. To date, there have been no large
longitudinal studies specifically designed to address
questions concerned with patterns of cannabis use and
personality that have included more than one personality
trait. Furthermore, the social contexts of drug taking and
adolescent development are ignored in many investigations.
The inclusion of more than one personality trait in a study
would permit teasing apart of the traits that lead young
people into initiating cannabis use and those that protect
against use per se and, perhaps more importantly, against
aberrant and intrusive patterns of cannabis use.
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